Dutch researcher discovers how sulfate groups can be protected during molecule construction

Sulfate groups are crucial building blocks for many molecules but are difficult to handle. Dutch researcher Martijn Huibers has discovered how sulfate groups can be protected during the construction of a molecule. Thanks to his method new molecules, which could be used for the production of medicines, can now be constructed far more easily.

Many sulfate groups are difficult to construct in molecules. This is partly because the products often dissolve in water and are therefore difficult to handle. Huibers solved this problem by incorporating the sulfates 'disguised' as so-called sulfite and sulfate diesters. These ensure that the sulfates remain protected during the construction process making them far easier to handle. The process is comparable to the construction of a house. During the construction you do not want to damage or break the windows and so you can protect them with wooden boards. Once the house has been completed, the boards can be removed. Just like wooden boards, the sulfite and sulfate diesters can be removed once the molecule has been constructed.

Huibers' method makes it far easier to construct organic molecules that contain sulfates. When sulfates are incorporated into molecules the yield can be very low, for example, about thirty percent; the rest is lost as a byproduct or during the purification process or it is destroyed. With Huibers' method the yield can frequently be increased to ninety percent or even more. Moreover, in theory his method makes it possible to incorporate sulfate molecules at any given moment and not only at the end of the construction process.

Drug development

Huibers is applying his new method of sulfate protection to many different molecules, including a compound that is active in the nervous system. The method has proven to be highly effective for a wide variety of constructions. With his discovery, Huibers has provided people like drug developers with a new tool.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-designed drug ISM5939 granted IND clearance for cancer clinical trials